Backgrounds/Aims: To determine the prevalence of post-hepatectomy liver failure/insufficiency (PHLF/I) in patients undergoing extensive hepatic resections for hepatocellular carcinoma (HCC) and to assess the predictive value of preoperative factors for post-hepatectomy liver failure or insufficiency (PHLF/I). Methods: A retrospective review of patients who underwent liver resections for HCC between 2001 and 2013 was conducted. Preoperative parameters were assessed and analyzed for their predictive value of PHLF/I. Definitions used included the 50-50, International Study Group of Liver Surgery (ISGLS) and Memorial Sloan Kettering Cancer Centre (MSKCC) criteria. Results: Among the 848 patients who underwent liver resections for HCC between 2001 and 2013, 157 underwent right hepatectomy (RH) and extended right hepatectomy (ERH). The prevalence of PHLF/I was 7%, 41% and 28% based on the 50-50, ISGLS and MSKCC criteria, respectively. There were no significant differences in PHLF/I between RH and ERH. Model for End-Stage Liver Disease (MELD) score and bilirubin were the strongest independent predictors of PHLF/I based on the 50-50 and ISGLS/MSKCC criteria, respectively. Predictive models were developed for each of the criteria with multiple logistic regression. Conclusions: MELD score, bilirubin, alpha-fetoprotein and platelet count showed significant predictive value for PHLF/I (all p<0.05). A composite score based on these factors serves as guideline for physicians to better select patients undergoing extensive resections to minimize PHLF. 
INTRODUCTION
Liver resection is curative for HCC when patients fail to qualify for liver transplantation. The recurrence rates post-hepatectomy have been reported at 70-85%. 4 Even in high-volume centers, liver resection is associated with significant morbidity and mortality rates, mostly due to hemorrhage, bile leaks, infection and post-hepatectomy liver failure or insufficiency (PHLF/I). PHLF is the most dreaded and least reversible, with incidence rates reported at approximately 8% in previous studies. 5 Sequelae and manifestations of PHLF/PHLI range from mild biochemical derangements to irreversible liver failure and death.
In addition to quantitative assessment of the future liver remnant (FLR), qualitative assessment is also important for preoperative prediction of PHLF. Currently, no vali-dated predictive models exist for PHLF/I particularly in the Asian population.
MATERIALS AND METHODS
This study aims to determine the prevalence of PHLF/I in patients diagnosed with HCC undergoing extensive hepatic resections, and investigate the predictive value of preoperative parameters for PHLF/I based on the pertinent criteria. Extensive hepatic resections are defined in this study as right hepatectomy (RH) and extended right hepatectomies (ERH), given that these procedures involve the most extensive liver volume resected, exposing patients to great risk for PHLF/I.
Study population
All patients derived from a single tertiary institution undergoing potentially curative liver resections for HCC be- are not common in our center for HCC cases, and to potentially eliminate unnecessary confounders in our study.
Criteria for post-hepatectomy liver failure/ insufficiency The criteria for PHLF/I were based on three internationally well-established models. 
Statistical analysis
All variables were assessed using univariate logistic regression. Those significant at p<0.20 were analyzed using a stepwise selection algorithm in a multivariate logistic regression model. Variables significant at p<0.20 in multivariate logistic regression analysis were then selected as the optimal subset of independent predictors for PHLF/I. These variables were used to form a predictive equation (y=b0+∑ k i=1 bixi) from which the probability of PHLF/I was calculated (p=e y /(1+e y )). Receiver operating characteristic (ROC) curves were plotted for each of the above models, where area under curve (AUC) was calculated to determine their validity as a predictive model.
RESULTS

Patient characteristics
The study population comprised 848 patients who un- Prevalence of post-hepatectomy liver failure/ insufficiency and associated mortality A total of 11 (7%), 44 Predictive models 50-50 criteria: Body mass index, albumin, bilirubin, (Table 3) .
Platelet count, MELD score and AFP were used to develop a model providing the strongest predictive value for PHLF. Using model coefficients, the model scores for y-intercept cut-offs (Y ) were selected at three distinct points (0.038, 0.045, and 0.046). Maximum sensitivity (100%) and specificity (54%) for this model was achieved at cut-offs of 0.038 and 0.046, respectively. (Table 4) The validity of this model was assessed using a ROC curve with an AUC of 0.78.
ISGLS criteria: Bilirubin, prothrombin time, total white cell count and MELD score were the factors most significantly associated with PHLF in univariate analysis.
Bilirubin (OR=2.39, p=0.03) and prothrombin time (OR=1.24, p=0.12) were selected as the optimal subset of independent predictors for PHLF after multivariate analysis (Table 3) Maximum sensitivity (100%) and specificity (51%) for this model was achieved at a cut-off of 0.129 and 0.222, respectively ( Table 4 ). The validity of this model was as- 17 -19 The relationship between PHLF and 90-day mortality in this study was only significant when the 50-50 criteria were used to define PHLF, which was not unexpected given that only the 50-50 criteria were devised as a predictor of increased risk of post-hepatectomy mortality. 6 Patients undergoing ERH were consistently at higher risk of PHLF when compared with those undergoing RH, although without statistical significance in our study.
Quantitative assessment of the FLR has been a well-established predictor of PHLF. Overly ambitious liver resections can leave a tiny FLR inadequate for compensatory hypertrophy in the critical post-operative period.
Resections up to 70-75% of the liver volume are deemed safe in patients with normal hepatic parenchyma. This volume decreases to 40-60% in patients with pre-existing parenchymal disease. 20 This finding is consistent with multiple reports stating that ERH and a diminished FLR were significant and independent predictors for PHLF. [21] [22] [23] [24] [25] Kauffmann and Fong. 21 reported that resection of >50% of liver volume, and major hepatectomy including the right hepatic lobe were both independent and significant predictors of PHLF. This study also reported that patients with an FLR <25% had a threefold risk of PHLF when compared with patients reporting an FLR ≥25%. Lee MELD score was initially developed to determine the risk of 3-month mortality in patients undergoing transjugular intrahepatic portosystemic shunt procedure, and has since been adapted as a prognostic indicator of 90-day survival in chronic liver disease under optimized medical management. 26 It was identified as a significant independent predictor for PHLF (50-50 criteria) in this study. Cucchetti et al. 27 similarly reported a MELD score ≥11 as an excellent cut-off value for predicting PHLF (sensitivity 82% and specificity 89%) and a high MELD score was significantly associated with morbidity (refractory ascites, coagulopathy, and renal impairment) and PHLF-related mortality. Bruix and Llovet 28 and Teh et al. 29 also reported the MELD score was the single most significant independent predictor of PHLF in patients undergoing hepatic resections. These studies further suggest that hepatic resection was only indicated in patients with a MELD score below 9, which is consistent with the findings of our study.
Thrombocytopenia was also identified as a significant independent predictor for PHLF (50-50 criteria) in this study. Kaneko et al. 30 reported that preoperative thrombocytopenia was a significant independent predictor of post-operative morbidity and mortality: no patient with a platelet count > 73×10 3 µL died of post-operative complications while 25% of patients with platelet counts < In addition, no patient with an AFP in excess of 50,000
(cutoff used for MAP score) had a maximum tumor diameter <10 cm. Given that only 2 patients in our study population of 157 underwent pre-operative CT volumetry, we used maximum tumor diameter as a surrogate marker for tumor volume. Kohla et al. 41 has reported that a high AFP is an independent predictor of post-transarterial chemoembolization (TACE) hepatic decompensation.
Prothrombin time was only significant in univariate analysis in the 50-50 (p=0.04) and ISGLS (p=0.04) criteria in this study. Among others, reports by Nanashima et al. 43, 44 and Motoyama et al. 36 suggested that elevated preoperative prothrombin time (>70-80% of normal ranges) independently predicted PHLF.
ICGR15 has been reported as an excellent guide for decision-making in determining a safe threshold of liver volume for resection (popularly known as the Makuuchi decision tree), and has had a great impact on minimizing mortality and morbidity in liver resection. 45 Although ICGR15 has been widely used as a predictor of overall survival in patients undergoing hepatectomy, its efficacy as a single pre-operative predictor of PHLF in patients undergoing major hepatic resections has, however, been poorly investigated. 45, 46 Studies by Yokoyama et al. 47 and
Uchida et al. 48 were This study presents with several limitations. This is a single center retrospective study with a modest sample size with its inherent biases. In this study, only 11 (7%) patients qualify for PHLF based on the 50-50 criteria, which is comparable to other centers worldwide. However additional and larger studies are needed to both internally and externally validate our results and the MAP score. 18, 22, 23, [48] [49] [50] Furthermore, current and newer assessment tools that add important information such as scintigraphy, CT volumetry, wedge pressures and ICGR15 were not adequately analyzed in our study due to limited data.
In conclusion, preoperative parameters such as MELD score, platelet count, AFP and bilirubin are significant predictors for PHLF in patients diagnosed with HCC undergoing extensive hepatic resections. The MAP score evaluated in this study can be used clinically by physi-
